About BriaCell Therapeutics
BriaCell Therapeutics is a company based in Beverly Hills (United States) founded in 2004.. The company has 18 employees as of July 31, 2024. BriaCell Therapeutics offers products and services including Bria-IMT, Bria-OTS, and Bria-OTS+. BriaCell Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Beverly Hills, United States
- Employees 18 as on 31 Jul, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Briacell Therapeutics Corp
-
Annual Revenue
$0 (USD)0as on Jul 31, 2024
-
Net Profit
$-4.52 M (USD)76.09as on Jul 31, 2024
-
EBITDA
$-31.41 M (USD)-44.81as on Jul 31, 2024
-
Latest Funding Round
$399.92 K (USD), Grant
Sep 01, 2023
-
Investors
HHS
& 4 more
-
Employee Count
18
as on Jul 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BriaCell Therapeutics
BriaCell Therapeutics is a publicly listed company on the TSX with ticker symbol BCT in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of BriaCell Therapeutics
BriaCell Therapeutics offers a comprehensive portfolio of products and services, including Bria-IMT, Bria-OTS, and Bria-OTS+. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Targets metastatic breast cancer through immune activation in clinical trials.
Provides off-the-shelf personalized treatment for breast and prostate cancers.
Enhanced version for various cancers, including prostate, via HLA matching.
Unlock access to complete
Unlock access to complete
Funding Insights of BriaCell Therapeutics
- Total Funding Total Funding
- Total Rounds 18
- Last Round Grant — $399,918
-
First Round
First Round
(23 May 2014)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2023 | Amount | Grant - BriaCell Therapeutics | Valuation |
investors |
|
| Aug, 2023 | Amount | Grant - BriaCell Therapeutics | Valuation |
investors |
|
| May, 2023 | Amount | Post-IPO - BriaCell Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BriaCell Therapeutics
BriaCell Therapeutics has secured backing from 5 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include HHS, National Cancer Institute and Prevail Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Limited information is provided about Prevail Partners' activities.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Cancer research is conducted and supported by the institute.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BriaCell Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BriaCell Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Briacell Therapeutics Comparisons
Competitors of BriaCell Therapeutics
BriaCell Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Briacell Therapeutics
Frequently Asked Questions about BriaCell Therapeutics
When was BriaCell Therapeutics founded?
BriaCell Therapeutics was founded in 2004 and raised its 1st funding round 10 years after it was founded.
Where is BriaCell Therapeutics located?
BriaCell Therapeutics is headquartered in Beverly Hills, United States. It is registered at Beverly Hills, California, United States.
How many employees does BriaCell Therapeutics have?
As of Jul 31, 2024, the latest employee count at BriaCell Therapeutics is 18.
What does BriaCell Therapeutics do?
Developer of immunotherapies for the treatment of cancer. Its lead product candidate, Bria-IMT is a genetically engineered whole-cell vaccine derived from a human breast cancer cell line. Bria-IMT is used in combination with multiple immune modulators to powerfully trigger the immune system to recognize and eliminate cancerous cells. Another product Bria-OTS is shelf-personalized immunotherapy for the treatment of advanced-stage breast cancer.
Who are the top competitors of BriaCell Therapeutics?
BriaCell Therapeutics's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does BriaCell Therapeutics offer?
BriaCell Therapeutics offers Bria-IMT, Bria-OTS, and Bria-OTS+.
Is BriaCell Therapeutics publicly traded?
Yes, BriaCell Therapeutics is publicly traded on TSX under the ticker symbol BCT.
Who are BriaCell Therapeutics's investors?
BriaCell Therapeutics has 5 investors. Key investors include HHS, National Cancer Institute, Prevail Partners, Wiseman Cancer Research Foundation, and Jamieson Bondarenko.
What is BriaCell Therapeutics's ticker symbol?
The ticker symbol of BriaCell Therapeutics is BCT on TSX.